Skip to main content
. 2013 Sep 4;16(1):18567. doi: 10.7448/IAS.16.1.18567

Table 4.

Current status of clinical trials of next-generation NNRTIs [97104]

Research code Generic name Sponsor Status
UK-453,061 Lersivirine ViiV Healthcare Phase IIb
GSK 2248761 (formerly IDX 899) ViiV Healthcare Phase IIb
RDEA806 Ardea Bioscience Phase IIa
BILR 355 BS Boehringer Ingelheim Pharmaceuticals Phase IIa
(+)-Calanolide A Sarawak MediChem Pharmaceuticals Phase I
MK-4965 Merck Research Laboratories Phase I
MK-6186 Merck Research Laboratories Phase I
MK-1439 Merck Research Laboratories Phase I